The present application provides novel solid state forms of Afatinib di-maleate, processes for preparing them, and pharmaceutical compositions containing them.Linvention concerne de nouvelles formes solides de dimaléate dAfatinib, leurs procédés de préparation et des compositions pharmaceutiques les contenant.